Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £788 | £877 | £1,000 | £908 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Cost of Goods Sold | £276 | £302 | £382 | £330 |
| Gross Profit | £512 | £575 | £618 | £579 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £449 | £373 | £309 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £456 | £0 | £0 | £0 |
| Operating Expenses | £456 | £449 | £427 | £353 |
| Operating Income | £56 | £126 | £181 | £228 |
| % Margin | 7.1% | 14.4% | 18.1% | 25.1% |
| Other Income/Exp. Net | -£47 | -£33 | -£31 | -£49 |
| Pre-Tax Income | £9 | £93 | £159 | £214 |
| Tax Expense | £4 | £24 | £31 | £33 |
| Net Income | £5 | £69 | £129 | £181 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46.2% | -27.8% | – |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| Weighted Avg Shares Out | 962 | 989 | 1,001 | 1,000 |
| Weighted Avg Shares Out Dil | 974 | 986 | 1,001 | 1,003 |
| Supplemental Information | – | – | – | – |
| Interest Income | £4 | £2 | £2 | £0 |
| Interest Expense | £29 | £31 | £18 | £14 |
| Depreciation & Amortization | £73 | £72 | £54 | £37 |
| EBITDA | £111 | £196 | £235 | £265 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |